Presentation as featured in our 'phygital' event (29 Oct 2020), hosted by Anneleen Tronquo (partner bluecrux) and Cédric Van Helleputte (Head of Planning Life Sciences bluecrux). Roundtable discussion together with 3 players of very well-recognized companies in life sciences (Bristol-Myers Squibb, Johnson & Johnson, and Novo Nordisk), on how they are experiencing their planning transformation journey.

1. PLANNING TRANSFORMATION JOURNEYS
IN LIFE SCIENCES

2. 22

3. 33

4. 44
Let’s go with this flow
INTRODUCTION
Getting to know the panel
members, their company and:
- Their role
- The scope of their planning
transformation
- How far advanced they are
in this transformation
EXPLORATION DISCUSSION
With the use of a poll, 6
questions are presented to the
attendees & can be answered
by means of a multiple
choice/open answer.
Our guests give you their
perspective on it
Any question you might
have we will take at the end
During the session write
your question in the chat
and we will take them at
the end

5. 55
What are we going to tackle today?
Q1
Trigger
Q2
Organisation
Q3
Process
Q5
Benefits
Q6
Learnings
Q4
Technology

6. 66
What was/is/will be the main reason for your
company to start your planning transformation?

7. 77
In which organizational areas did you/will you invest
the most as part of your planning transformation?

8. 88
As part of your transformation you redefined
processes: on which processes did you focus the
most on?

9. 99
What is your technology stack strategy with
regards to planning solutions?

10. 1010
Working capital reduction is an often realized benefit
through comprehensive planning transformations, but
what were/are/will be the most important levers in
your journey?

11. 1111
What was/is your most important lesson learnt so
far?

12. 1212